Logo - springer
Slogan - springer

Medicine - Neurology | Molecular Autism

Molecular Autism
BioMed Central

Molecular Autism

Editors-in-Chief: J.D. Buxbaum; S. Baron-Cohen

ISSN: 2040-2392 (electronic version)

Journal no. 13229

BioMed Central

Open access BioMed Central
  • About this journal

  • Welcomes research across all levels - from molecule to behavior
  • Highest ranking journal dedicated to autism and related developmental disorders
  • Open access: over 30,000 article accesses per month

Molecular Autism is a peer-reviewed, online open access journal that publishes high-quality basic, translational and clinical research that has relevance to the etiology, pathobiology, or treatment of autism and related neurodevelopmental conditions. Research that includes integration across levels is encouraged. Molecular Autism publishes empirical studies, reviews, and brief communications.

Related subjects » Molecular Medicine - Neurology - Neuropsychology - Neuroscience - Pediatrics - Psychiatry

Impact Factor: 5.486 (2013) * 

Journal Citation Reports®, Thomson Reuters

Abstracted/Indexed in 

PubMed, PubMedCentral, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, EBSCO, Academic OneFile, Academic Search, Expanded Academic, Health Reference Center Academic, Index Copernicus, OCLC, Summon by ProQuest

Read This journal on BioMed Central

For authors and editors


  • Journal Citation Reports®, Thomson Reuters
    2013 Impact Factor
  • 5.486
  • Aims and Scope

    Aims and Scope

    Close

    Molecular Autism is a peer-reviewed, online open access journal that publishes high-quality basic, translational and clinical research that has relevance to the etiology, pathobiology, or treatment of autism and related neurodevelopmental conditions. Research that includes integration across levels is encouraged. Molecular Autism publishes empirical studies, reviews, and brief communications. We encourage submission of empirical studies of autism from a range of fields including (but not restricted to) genetics, molecular neurobiology, neuropathology, neuroimaging, cognitive neuroscience, epidemiology, and biomarker discovery. Molecular Autism also publishes articles on screening, diagnosis and classification, including articles that consider subgrouping to refine our understanding of basic mechanisms. Intervention studies are also welcome, especially when considered with respect to revealing causal mechanisms.

    Although the primary focus is on conditions on the autism spectrum (including Asperger syndrome), the scope encompasses molecular research into related neurodevelopmental conditions such as specific language impairment, dyspraxia, and specific or general developmental delays; and into related medical syndromes such as fragile X syndrome, tuberous sclerosis, and Rett syndrome.

    Molecular Autism also considers articles with no molecular data but which, in the long-term, may close the gap from molecule to behavior in autism. The journal welcomes reports and reviews of good science that proceed from either end of this complex chain of events: from molecule upwards, or from behavior downwards. Reports and reviews can be basic and/or translational.

  • Submit Online
  • English Language Editing

    English Language Editing

    Close

  • Author Academy: Training for Authors